{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-274543","form_type":"8-K","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.470677+00:00","generated_at":"2026-06-08T08:26:04.242764+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ResMed appoints new CPO, CMO, CRO; COO Douglas to retire Jan 1, 2024","bullets":["Rob Douglas, President & COO, retires Jan 1, 2024; transitions to special advisor to CEO immediately.","Justin Leong named Chief Product Officer, Katrin Pucknat as CMO, Mike Fliss as CRO, effective immediately.","Lucile Blaise moves from president sleep & respiratory care to SVP strategy & business development.","New operating model sets product-led, customer-centric, brand-enhanced focus to accelerate profitable growth.","Former CTO Urvashi Tyagi becomes special advisor to CPO through Jan 1, 2024; consulting through Dec 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-274543","json":"https://secwatch.observer/filing/0001193125-23-274543.json","markdown":"https://secwatch.observer/filing/0001193125-23-274543.md","text":"https://secwatch.observer/filing/0001193125-23-274543.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312523274543/0001193125-23-274543-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312523274543/d287548d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T08:26:04.242764+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e088e1dd7","claim":"Robert Douglas retired as special advisor to the CEO at RESMED INC.","evidence_excerpt":"On November 9, 2023, we announced that Robert Douglas, our chief operating officer and president, will transition to a role as special advisor to the CEO effective immediately and will retire, effective January 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312523274543/0001193125-23-274543-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"special advisor to the CEO"}],"fact_type":"executive_change"},{"claim_id":"2289777444","claim":"Robert Douglas changed role as special advisor to the CEO at RESMED INC.","evidence_excerpt":"On November 9, 2023, we announced that Robert Douglas, our chief operating officer and president, will transition to a role as special advisor to the CEO effective immediately and will retire, effective January 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312523274543/0001193125-23-274543-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"special advisor to the CEO"}],"fact_type":"executive_change"},{"claim_id":"50dab7009b","claim":"Lucile Blaise changed role as senior vice president, strategy & business development at RESMED INC.","evidence_excerpt":"Lucile Blaise, our former president, sleep & respiratory care, will transition to a role as senior vice president, strategy & business development, reporting to our Chief Strategy Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312523274543/0001193125-23-274543-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"senior vice president, strategy & business development"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}